GATA2 and acute myeloid leukemia: Hereditary MDS/AML, rather than immune dysfunction, is the principle clinical feature of several kindreds with GATA2 mutation (Hahn et al, 2011; Bodor et al, 2012; Holme et al, 2012; Ishida et al, 2012; Fujiwara et al, 2014).